Taking Gaviscon with Mounjaro: what you need to know

Step 1: understand why digestion changes on Mounjaro

Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist, the only medicine in the UK to activate both gut-hormone pathways involved in appetite regulation and blood-sugar control. One of those pathways slows gastric emptying: food and fluids leave the stomach more gradually than usual. That is largely why people feel fuller for longer on treatment. It is also why acid reflux, burping, nausea and indigestion appear on the list of recognised side effects, particularly in the early weeks or after a dose step.

For many people, this gastric slowing is mild and settles within a fortnight. For others it is persistent enough to prompt a search for relief. If you have found yourself reaching for Gaviscon since starting Mounjaro, that experience is extremely common, and it makes sense to understand the mechanics before deciding when and how to take it.

The NHS tirzepatide page lists indigestion and reflux among the common side effects of Mounjaro, which is a useful first reference if you want to understand what the medicine is doing in your digestive system. If you are curious about how the active ingredient is prepared, our page on lyophilized tirzepatide explains the formulation process and what it means for how the medicine is stored and used.

Step 2: how Gaviscon works and why the pharmacology matters

Gaviscon forms a physical raft on top of stomach contents, creating a barrier that reduces the likelihood of acid refluxing into the oesophagus. It is not absorbed into the bloodstream in meaningful amounts; it acts locally. That distinction matters. A medicine that is absorbed systemically and competes for the same receptor pathways would raise genuine interaction concerns. Gaviscon does not do that.

However, the slowed gastric emptying caused by Mounjaro does create one practical consideration. Anything in the stomach takes longer to move on. If you take Gaviscon alongside other oral medicines (a blood-pressure tablet, an antibiotic, an oral contraceptive) those medicines may also be delayed in reaching the small intestine where most absorption happens. For Gaviscon itself this is largely irrelevant, since it never needed to be absorbed to do its job. The concern is really about what else you might be taking at the same time.

This is also why the prescribing information advises that people on Mounjaro who take other oral medicines should discuss timing with their prescriber or pharmacist. Spacing medicines sensibly (rather than swallowing everything at once) is a practical way to reduce any slowing effect on absorption.

Step 3: practical guidance on timing and what to watch for

There is no specific clinical warning against taking Gaviscon and Mounjaro together, and for most people it is a reasonable short-term response to reflux discomfort. That said, a few practical points are worth keeping in mind.

If your reflux symptoms are persistent rather than occasional, mention them at your next clinical review. Persistent reflux on Mounjaro sometimes responds to dietary adjustments (smaller meals, lower-fat choices, eating more slowly) rather than a long-term antacid. A clinician can also check whether the dose timing of Mounjaro could be adjusted, or whether the reflux is unrelated to the treatment altogether. People with pre-existing gastrointestinal conditions may find this conversation particularly useful.

If you are also managing symptoms related to HRT or other hormone treatments alongside Mounjaro, interactions with those medicines carry their own separate considerations that your prescriber can walk through with you.

In the meantime, taking Gaviscon at least 30 minutes after other medicines is sensible as a general principle. And if the reflux is new, severe, or accompanied by pain that radiates to the back, that warrants prompt medical attention rather than self-management with an over-the-counter product. Severe persistent stomach pain is one of the symptoms the MHRA flagged in their January 2026 Drug Safety Update as requiring urgent medical review for people on GLP-1 medicines, you can report any suspected side effects at the MHRA Yellow Card scheme.

Step 4: what your prescriber looks at in a repeat clinical review

At nume, every repeat order involves a fresh clinical review, a real prescriber reads your current information before anything is dispensed. That review is the right moment to raise any ongoing symptoms, including reflux, and any over-the-counter products you have added to manage them. You can also raise questions through our aftercare team, seven days a week.

Questions about managing other medicines alongside Mounjaro (whether that is a second GLP-1 product or a supplement like NAD) benefit from the same individual clinical lens. There is no one-size answer, because your full medication list, dose, and how long you have been on treatment all shape what is sensible for you specifically.

If you are still in the early stages of weighing up what Mounjaro involves, or you are considering starting, our prescribers are available to discuss the full picture. Speak to our prescribers through a free consultation to get a personalised view of how treatment fits with everything else you take.